HUE035859T2 - Cladribine dosing regimen for multiple sclerosis - Google Patents

Cladribine dosing regimen for multiple sclerosis Download PDF

Info

Publication number
HUE035859T2
HUE035859T2 HUE14001970A HUE14001970A HUE035859T2 HU E035859 T2 HUE035859 T2 HU E035859T2 HU E14001970 A HUE14001970 A HU E14001970A HU E14001970 A HUE14001970 A HU E14001970A HU E035859 T2 HUE035859 T2 HU E035859T2
Authority
HU
Hungary
Prior art keywords
cladribine
months
period
administered
dose
Prior art date
Application number
HUE14001970A
Other languages
English (en)
Hungarian (hu)
Inventor
Luca Giampiero De
Arnaud Ythier
Alain Munafo
Maria Lopez-Bresnahan
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of HUE035859T2 publication Critical patent/HUE035859T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Pressure Welding/Diffusion-Bonding (AREA)
HUE14001970A 2004-12-22 2005-12-20 Cladribine dosing regimen for multiple sclerosis HUE035859T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63866904P 2004-12-22 2004-12-22
EP04106909 2004-12-22

Publications (1)

Publication Number Publication Date
HUE035859T2 true HUE035859T2 (en) 2018-05-28

Family

ID=34930135

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14001970A HUE035859T2 (en) 2004-12-22 2005-12-20 Cladribine dosing regimen for multiple sclerosis

Country Status (10)

Country Link
AT (1) ATE547106T1 (pt)
DK (1) DK1827461T3 (pt)
ES (4) ES2428741T3 (pt)
HU (1) HUE035859T2 (pt)
LT (1) LT2805723T (pt)
ME (1) ME01333B (pt)
PT (3) PT2805723T (pt)
RS (1) RS52219B (pt)
SI (1) SI1827461T1 (pt)
UA (1) UA96260C2 (pt)

Also Published As

Publication number Publication date
DK1827461T3 (da) 2012-03-26
RS52219B (en) 2012-10-31
LT2805723T (lt) 2018-02-12
ATE547106T1 (de) 2012-03-15
PT2805723T (pt) 2018-01-25
ES2382554T3 (es) 2012-06-11
ES2666146T3 (es) 2018-05-03
SI1827461T1 (sl) 2012-05-31
ES2495392T3 (es) 2014-09-17
ME01333B (me) 2013-12-20
UA96260C2 (ru) 2011-10-25
PT1827461E (pt) 2012-05-07
ES2428741T3 (es) 2013-11-11
PT3332789T (pt) 2022-07-05

Similar Documents

Publication Publication Date Title
JP6430554B2 (ja) 多発性硬化症を治療するためのクラドリビン投薬計画
US9925151B2 (en) Cladribine regimen for treating multiple sclerosis
HUE035859T2 (en) Cladribine dosing regimen for multiple sclerosis
NZ572680A (en) Cladribine and interferon-beta regimen for treating multiple sclerosis